These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9213204)

  • 21. Effects of sildenafil citrate on human hemodynamics.
    Jackson G; Benjamin N; Jackson N; Allen MJ
    Am J Cardiol; 1999 Mar; 83(5A):13C-20C. PubMed ID: 10078538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
    Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
    Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.
    Dickstein K; Gottlieb S; Fleck E; Kostis J; Levine B; DeKock M; LeJemtel T
    J Hypertens Suppl; 1994 Jul; 12(2):S31-5. PubMed ID: 7965263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
    Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA
    Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive inotropic and vasodilatory actions of saterinone in vivo.
    Armah BI; Hofferber E; Jacobitz P
    Arzneimittelforschung; 1988 Sep; 38(9):1303-9. PubMed ID: 2906247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term vasodilator treatment with flosequinan does not lead to hemodynamic tolerance or neurohormonal activation in severe heart failure.
    Bartels GL; Remme WJ; Look MP; Kruijssen DA
    J Card Fail; 1995 Mar; 1(2):117-25. PubMed ID: 9420641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of saterinone and its enantiomers R(+)-saterinone and S(-)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts.
    Zimmermann W; Scholz H; Schumacher C; Wenzlaff H; Haverich A
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):611-8. PubMed ID: 7526225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
    Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
    Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.
    De Tommasi E; Iacoviello M; Romito R; Ceconi C; Guida P; Massari F; Francolini G; Bertocchi F; Ferrari R; Rizzon P; Pitzalis MV
    Am Heart J; 2003 Nov; 146(5):E17. PubMed ID: 14597946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure.
    Aronson D; Burger AJ
    Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):98-106. PubMed ID: 11333166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
    Leier CV; Lima JJ; Meiler SE; Unverferth DV
    Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
    Schofer J; Hobuss M; Aschenberg W; Tews A
    Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
    Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
    Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of alpha1-adrenoceptor antagonist, doxazosin, in patients with chronic congestive heart failure.
    Kieback AG; Rödiger O; Jaenecke H; Grohmann A; Wernecke KD; Baumann G; Felix SB
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):399-404. PubMed ID: 16160589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
    Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autonomic and hemodynamic effects of a new selective dopamine agonist, CHF1035, in patients with chronic heart failure.
    Tjeerdsma G; van Wijk LM; Molhoek GP; Boomsma F; Haaksma J; van Veldhuisen DJ
    Cardiovasc Drugs Ther; 2001 Mar; 15(2):139-45. PubMed ID: 11669407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologic assessment of milrinone therapy in severe heart failure patients.
    Dubois-Randé JL; Duval-Moulin AM; Saal JP; Merlet P; Lellouche D; Deleuze P; Dupouy P; Brun P; Loisance D; Castaigne A
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):941-8. PubMed ID: 1714019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.